Trademark: SNAKE PHARM THE FUTURE OF ANTIVENOM
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
SNAKE PHARM THE FUTURE OF ANTIVENOM
Click here to search for trademarks similar to SNAKE PHARM THE FUTURE OF ANTIVENOM
Proof of use for SNAKE PHARM THE FUTURE OF ANTIVENOM
We do not have any records of a proof of use for SNAKE PHARM THE FUTURE OF ANTIVENOM at this moment.
Click here to add a proof of use for SNAKE PHARM THE FUTURE OF ANTIVENOM
Possible trademark infringements of SNAKE PHARM THE FUTURE OF ANTIVENOM
Basic Information about SNAKE PHARM THE FUTURE OF ANTIVENOM
- Serial Number
- 87839272
- Filing Date
- 19 Mar 2018
- Registration Number
- 5610457
- Registration Date
- 20 Nov 2018
- Mark Drawing Code
- 3
Classifications
Declare the trademark use of SNAKE PHARM THE FUTURE OF ANTIVENOM on the blockchain with WikiTrademarks.io.
- First use of SNAKE PHARM THE FUTURE OF ANTIVENOM anywhere
- SNAKE PHARM THE FUTURE OF ANTIVENOM was first used on 25 Apr 2016 for the primary classification of goods and services, international, 005 (Pharmaceuticals)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 005
- US Codes
- 006; 018; 044; 046; 051; 052
Who owns SNAKE PHARM THE FUTURE OF ANTIVENOM?
1. Snake Pharm Enterprises Irvine CA
2. Snake Pharm Enterprises Irvine CA
3. Snake Pharm Enterprises Irvine CA
Correspondent
- Thomas Dunlap
- Dunlap Bennett & Ludwig PLLC
- 211 Church Street SE
- Leesburg VA 20175
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io